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This latest Optical Diagnosis themed
issue of Analyst, guest-edited by Prof.
Malgorzata Baranska, Jagiellonian University, Krakow, Poland, and Prof. Hugh
J. Byrne, Dublin Institute of Technology,
Ireland, is drawn from the participants
and proceedings of the International
conference, SPEC 2014: Shedding New
Light on Disease, which was held on the
17th–22nd August 2014 in Krakow,
Poland. The conference was co-chaired
by Prof. Baranska, Prof. Byrne and Prof.
Anna Sulkowska, Medical University of
Silesia, Katowice, Poland.
The event was the eighth in the series
of biennial conferences, the aim of
which is to bring together clinicians and
scientists who have joined forces in the
quest for novel biomedical applications
of infrared and Raman spectroscopy to
improve patient care. Recent advances in
the biological sciences and medicine
have led to an increasing demand for
real-time and minimally invasive chemical and structural information on biological materials. Due to its unique
fingerprinting capability, vibrational
spectroscopy plays a significant role in
histopathology, cytology, biopsy targeting, surgical targets, treatment-monitoring and drug studies.
The conference aimed to highlight
further advances in state of the art and
emerging biomedical applications of
vibrational spectroscopy, while reviewing
the challenges in the context of other
emerging technologies. The programme
was constructed in an attempt to prioritise real-world applications from the
outset, systematically progressing from
research towards in-vivo, ex-vivo and
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in-vitro applications, as well as emerging
technologies and data processing.
A feature of the conference was the
daily discussion sessions which were
aimed at a critical assessment of the
routes towards the further development
of clinical applications, and were
moderated by members of the SPEC
International Advisory Board. The deliberations are summarised in the second
editorial ‘Spectropathology for the next
generation: Quo vadis?’ (Byrne et al.,
c4an02036g), under the headings of
(i) Translational research into in-vivo
clinical applications, (ii) Ex-vivo tissue
biopsies, body fluids and cytological
samples for diagnostics and disease
studies, and (iii) In-vitro cell culture and
3D models for research and medical
applications. A number of critical concerns are highlighted under the respective headings, including (i) the need for
the engagement with the clinical community and adherence to clinical standards in terms of statistical relevance,
(ii) standardisation of protocols for
sample preparation, presentation and
measurement and data processing, and
(iii) continued development of instrumentation and models to explore the
limitations of the techniques.
The scope of the conference and the
contents of this themed issue are indicative of the progress in the understanding
of the complexity of spectroscopic
characterisation of biological materials,
and data preprocessing and postprocessing methods can increasingly be
applied with confidence to give true biochemical representations of tissue, cells
and bodily fluids. The issue contains a

total of 51 contributed communications
and articles, drawing from research
activities across the globe, including
Australia, India, Japan, US and across
Europe with a notably strong representation from the host country, Poland.
The increased development of fibre
probes shows great promise for in-vivo
diagnosis and intra-operative applications, and although Raman probes –
operating at visible or near-infrared
wavelengths – are relatively well established, probes for FTIR spectroscopy
are less so. The study by Padalkar and
Pleshko (c4an01987c) details the development of such probes for the in-vivo
analysis of cartilage.
For clinical applications, the research
field remains dominated by ex-vivo applications of tissue, cells and biofluids.
Spectrohistopathological studies using
either FTIR or Raman profiling range
from analysis of cancer markers
in adrenal glands (Dudala et al.,
c4an01891e), salivary tissue (BrozekPluska et al., c4an01394h), lung tumour
(Gerwert et al., c4an01978d), breast
tissue (Abramczyk et al., c4an01876a;
Brozek-Pluska et al., c4an01877j), and
primary and metastatic melanoma
(Wald and Goormaghtigh, c4an01831a).
Further studies include analysis of the
pituitary
gland
(Banas
et
al.,
c4an01985g), calcification of the aortic
valve (Kaczor et al., c4an01856g), the
vitamin A content in murine lung and
liver tissue (Marzec et al., c4an01881h;
Baranska et al., c4an01878h) and endothelial function/dysfunction (Kaczor et al.,
c4an01870b; Rygula et al., c4an01998a).
Animal models also feature strongly in
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the studies of Chwiej et al. (c4an01857e)
as epileptic models, and as obesity
models in the work of Severcan et al.
(c4an02008a).
Cytological studies, using FTIR and
FTIR-ATR spectroscopy also feature
strongly, in, for example, the study by
Diem et al. (c4an01884b) of oesophageal
cells. Abramczyk et al. (c4an01875c)
demonstrate the role of lipid droplets
and adipocytes in cancer by comparing
the Raman spectral profiles of cell cultures to those of adipocytes in cancerous
human breast tissue.
The contents of this issue reflect an
increasing prominence of studies of
blood cells (Wood et al., c4an01904k)
and peripheral blood lymphocytes
(Goormaghtigh et al., c4an01855a and
c4an02247e), and indeed of bodily fluids
themselves, using both FTIR and Raman
spectroscopy, notably blood plasma
(Šťovíčková et al., c4an01874e; Malek
et al., c4an01864h; Garnotel et al.,
c4an01942c; Tatarkovič et al., c4an01880j)
and serum (Chilakapati et al., c4an01860e),
potentially promising more accessible
routine screening applications of vibrational
spectroscopy.
Spectroscopic techniques remain a
powerful tool for basic research and may
find applications in vitro for toxicology
and drug screening, as exemplified by
the study of cellular uptake of doxorubicin by Chlopicki, Baranska and coworkers (c4an01882f ), and the study of
the biocompatibility of nanocomposites by Wesełucha-Birczyńska et al.
(c4an02284j), Malek et al. (c4an01988a),
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and Campbell et al. (c4an02365j),
demonstrate the use of SERS-based
nanosensors to monitor the intracellular
pH in endothelial cells. Equally, such
in-vitro studies can provide valuable
explorations for new 3D cell culture
models (Smolina and Goormaghtigh,
c4an01833h), developing neural systems
(Sato et al., c4an01961j) and disease
models (malaria) (Hobro, Smith and coworkers, c4an01850h). Mosig et al.
(c4an02153c) demonstrate the colocalization of fluorescence and Raman microscopic images for the identification of
subcellular compartments, and thus the
potential of the technique for in-vitro
screening.
Although the proof of concept of a
range of potential clinical applications
of vibrational spectroscopy has been well
demonstrated, there remains the need
for standardisation of measurement protocols and data processing, as highlighted in the discussion editorial (Byrne
et al., c4an02036g). Exploration of the
impact of tissue processing (Stone et al.,
c4an02122c; Wood et al., c4an02034k) as
well as measurement configurations for
FTIR spectroscopy (Gardner et al.,
c4an01975j; Mignolet and Goormaghtigh,
c4an01834f; Wood et al., c4an01901f;
Malek et al., c4an01842g) feature
strongly. Gardner et al. (c4an02053g)
also propose protocols for enhanced
FTIR bench-top imaging of single biological cells. The relative merit of
diﬀerent classification and data-mining
algorithms continues to be a subject for
investigation (Wood et al., c4an01783h;

Surowka et al., c4an01867b; Gobinet
et al., c4an01937g; Diem et al.,
c4an01832j and c4an01879f; Meade
et al., c4an01887g), while Keating et al.
(c4an02167c) demonstrate the importance of simulated datasets for method
validation.
Emerging technologies continue to
push the performances in terms of
spatial resolution (Gough et al.,
c4an01982b), sampling depth (Ariese
et al., c4an01889c) and the emergence of
quantum cascade lasers as IR sources
promises increased scanning speeds for
large area spectral mapping (Kröger-Lui
et al., c4an02001d). Meanwhile, Czepiel,
Wesełucha-Birczyńska and co-workers
(c4an01947d) give glimpses into applications beyond human pathologies.
The field of clinical applications of
vibrational spectroscopy continues to
engage
a
broad
interdisciplinary
research community across the world,
including spectroscopists, chemists, biochemists etc. The field is furthermore
becoming increasingly intersectoral, as
instrument companies address the challenge of faster acquisition speeds over
larger areas, and the medical community
itself becomes more ‘spectrophilic’ and
engaged in promoting the potential of
spectropathology for the next generation.
We hope you find the articles gathered
in this themed issue of Analyst stimulating and inspiring.
Malgosia Baranska
Jagiellonian University, Krakow, Poland
Hugh J. Byrne
Dublin Institute of Technology, Ireland
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